Pan Pacific Lymphoma ConferencePan Pacific Lymphoma Conference20182018

Monday-Friday, July 16-20

Hyatt Regency Maui Resort & SpaLahaina, Hawaii

Join us for a 5-day comprehensive educational conference with expert faculty from around the globe presenting the most up-to-date clinical advances in lymphoma and transplantation.

Register by May 15, 2018 to receive the discounted rate.

Go to unmc.edu/panpacificlymphomaPan Pacific Lymphoma Conference Brochure Last updated on May 30, 2018

The University of Nebraska Medical Center, Center for Continuing Education invites you to participate in the 2018 Pan Pacific Lymphoma Conference on July 16-20, 2018 at the Hyatt Regency Maui Resort & Spa, Lahaina, Hawaii.

Trusted for more than two decades for its educational excellence, this international conference brings together more than 400 members of the multidisciplinary lymphoma clinical team including oncologists, hematologists, pathologists, clinical scientists, nurse practitioners, physician assistants, nurses, and pharmacists. A full complement of research and clinical case presentations, symposiums, posters, and exhibits make this conference one of the largest gatherings of clinicians and researchers specializing in the areas of lymphoma and transplantation.

The 2018 conference will include scientific sessions Monday through Friday, and two-hour symposiums throughout the conference.

Conference ObjectivesAt the conclusion of the conference, the attendee should be better able to:

1. Evaluate results of clinical trials with current and emerging agents and regimens to develop evidence-based clinical management strategies in patients with Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL)

2. Formulate evidence-based management strategies for the optimal management of patients with lymphoma, leukemia and myeloma, inclusive of multi-modality therapies and maintenance-based regimens

3. Analyze underlying molecular and cytogenetic abnormalities contributing to hematologic malignancies and their impact on diagnosis, prognosis, and therapeutic approaches

4. Evaluate the optimal patient selection, timing, and regimen for stem cell transplant and chimeric antigen receptor (CAR-T) cell therapy for patients with lymphoma

5. Personalize the treatment of hematologic malignancies based upon patient and disease-specific characteristics, and manage treatment-related adverse effects appropriately

6. Provide accurate and appropriate counsel as part of the treatment plan

7. Review factors that impact patient selection, availability, and enrollment into clinical trials examining novel agents under investigation in patients with lymphoma, leukemia, and myeloma

Registration FeesPARTICIPANTS

By May 15 After May 15

Physicians $675 $775Nurses and All Other Healthcare Providers $475 $575Pharmaceutical and Other Healthcare Industry Attendees $1000 $1250

The participant registration fee includes all scientific sessions, continental breakfasts, welcome reception on Tuesday, conference dinner on Thursday, symposiums, and continuing education credit.

Conference VenueHyatt Regency Maui Resort & Spa 200 Nohea Kai Drive Lahaina, Hawaii 96761

How to RegisterONLINE unmc.edu/panpacificlymphoma

BY MAILCenter for Continuing Education University of Nebraska Medical Center 986800 Nebraska Medical Center Omaha, NE 68198-6800

BY PHONE+1-402-559-5929* +1-877-832-6924* (Toll Free)

*Available Monday through Friday from 8 a.m. to 4 p.m. CT

BY FAX+1-402-559-5915

For More InformationContact Brenda Ram, CMP, CHCP bram@unmc.edu +1-402-559-9250

2018 Pan Pacific Lymphoma Conference

ACCOMPANYING GUESTSThe fee for each accompanying guest over the age of 12 is $225. There is no fee for children under the age of 12. Accompanying guests may join conference participants during continental breakfasts and breaks (as part of the main conference) from Monday through Friday, the welcome reception on Tuesday, and the conference dinner on Thursday.

Name tags will be issued and required for attendance at these conference food functions.

Full payment must accompany each conference registration.

Registration Deadline: June 22, 2018

Cancellation PolicyAll cancellations must be submitted in writing either by mail, email, or fax to the UNMC Center for Continuing Education. Cancellations after May 15, 2018 will be charged a $350 processing fee. No refund will be given after this date.

Continuing Education CreditPHYSICIANSThe University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 29 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSESThe University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is provided for up to 29.0 contact hours under ANCC criteria.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation (ANCC) through the joint providership of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education (UNMC CON CNE) (provider), University of Nebraska Medical Center, Center for Continuing Education (UNMC CCE), and the Postgraduate Institute for Medicine (PIM).

PHARMACISTSIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The University of Nebraska Medical Center, Center for Continuing Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Postgraduate Institute for Medicine designates this continuing education activity for 29 contact hour(s) (0.29 CEUs) of the Accreditation Council for Pharmacy Education.

*PENDING - (Universal Activity Number - 0809-xxxx-xx-xxx-xxx-x)

The satellite symposiums held in conjunction with this conference will also be CME/CE accredited by UNMC CCE and UNMC CON CNE.

Conference MaterialsBring your own technology! Conference participants may access conference materials using a computer, tablet, or smart phone via the conference app.

Disclosure PolicyIt is the policy of the UNMC CCE, UNMC CON CNE, and PIM to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All planners, faculty and other individuals who are in a position to control the content of this activity are required to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted and resolved according to UNMC CCE, UNMC CON CNE, and PIM policy. The existence or absence of COI for anyone in a position to control content will be disclosed to participants prior to the start of the activity.

ADAIn compliance with the Americans with Disabilities Act, the UNMC CCE does not discriminate on the basis of disability. The Center shall provide reasonable accommodation, including auxiliary aids and services, to ensure equal access to its services and activities. If you would like an auxiliary aid or service, please call 402-559-9250 by May 30, 2018 with your request.

SponsorsThis conference is co-sponsored by the UNMC Department of Internal Medicine – Division of Oncology and Hematology, the UNMC CON CNE, and PIM, through the resources of the UNMC CCE.

Monday, July 16, 2018 Interprofessional Education Day

7:00 a.m. Conference Registration / Continental Breakfast

MODERATORS: Susan Blumel, RN, BSN/Matthew A. Lunning, DO

7:45 a.m. WelcomeMatthew A. Lunning, DO

8:00 a.m. Future Trends in Lymphoma Care/Administrative and Economic Implications Philip J. Bierman, MD Theresa Franco, MSN, RN

8:40 a.m. Immunotherapy Laura Zitella, MS, RN, ACNP-BC, AOCN

9:10 a.m. CAR-T Cell Toxicities and Team ManagementSusan Blumel, RN, BSN

9:40 a.m. Pharmacologic Supportive CareSusanne E. Liewer, PharmD, BCOP, FHOPA

10:10 a.m. Refreshment Break

10:25 a.m. Ethical Considerations (Medical Marijuana, Physician Assisted Suicide, Navigating Alternative Therapies During Treatment)Jean Ridgeway, DNP, APN, NP-C, AOCN R. Gregory Bociek, MD, MSc, FRCP(C)

11:05 a.m. Geriatric Oncology for Patients with LymphomaPeggy Burhenn, MS, RN-BC, AOCNS

11:35 a.m. Survivorship – Fertility and Sexual Issues in Lymphoma Patients Katrina Pose Sabati, MPA, PA-C

12:15 p.m. Adjourn

Tuesday, July 17, 2018 7:00 a.m. Continental Breakfast

7:30 a.m. WelcomeJulie M. Vose, MD, MBA

Bench to BedsideMODERATORS: Julie M. Vose, MD, MBA/Daniel J. DeBehnke, MD, MBA

7:40 a.m. Update on the WHO Classification of LymphomaDennis D. Weisenburger, MD

8:05 a.m. Immune Evasion and Engagement in Lymphoma Stephen M. Ansell, MD, PhD

8:30 a.m. Clinical Use of Cell Free DNA in Lymphoma David M. Kurtz, MD, PhD

8:55 a.m. Clinical Applications of Genomic Studies in NHLAndrew D. Zelenetz, MD, PhD

9:20 a.m. First James O. Armitage Lymphoma Clinical Investigator AwardMatthew S. Davids, MD, MMSc

9:50 a.m. Refreshment Break

Novel Therapies in LymphomaMODERATORS: Richard I. Fisher, MD/Jeffrey P. Gold, MD

10:05 a.m. First Oliver Press Memorial Lecture Update on CAR-T Cell Therapies for NHLDavid G. Maloney, MD, PhD

10:30 a.m. Novel Cell Pathway Targeted Agents for Lymphoma Therapy Julie M. Vose, MD, MBA

10:55 a.m. Novel-Novel Drug Combination in B-Cell MalignanciesKieron M. Dunleavy, MD

11:20 a.m. New Monoclonal Antibodies and Antibody Drug ConjugatesBrad S. Kahl, MD

11:45 a.m. How Do We Incorporate PET/CT Scanning into Standard of Care and Research Studies?Bruce D. Cheson, MD

12:10 p.m. Use of Deauville Versus Delta SUV in Response Evaluation for LymphomaNeil J. Hansen, MD

12:35 p.m. Adjourn

Conference Agenda

Ask the Experts

3:00 p.m. Clinical Cases Discussing Timing, Responses, and Toxicity of CAR-T Cell Therapy for CD19+ Non-Hodgkin LymphomaMODERATOR: R. Gregory Bociek, MD, MSc, FRCP(C) Leo I. Gordon, MD, FACPStephen J. Schuster, MDJulie M. Vose, MD, MBA

4:00 p.m. Clinical Cases Discussing Upfront, Relapsed, and Transplant Options for Patients with Multiple MyelomaMODERATOR: Matthew A. Lunning, DOSergio A. Giralt, MD Sarah A. Holstein, MD, PhD Sagar Lonial, MD

5:00 p.m. Adjourn

7:00 p.m. Welcome Reception

Wednesday, July 18, 2018 7:00 a.m. Continental Breakfast

High Grade B-Cell LymphomaMODERATORS: Wyndham H. Wilson, MD, PhD/Daniel J. DeBehnke, MD, MBA

7:30 a.m. Update on Pathology for High Grade B-Cell Lymphomas (HGBCL)Timothy C. Greiner, MD

7:55 a.m. Optimum Therapy for Standard Risk HGBCL Nancy L. Bartlett, MD

8:20 a.m. Upfront Therapies For HGBCL With Comorbidities Laurie H. Sehn, MD, MPH

8:45 a.m. Therapy for Double/Triple Hit HGBCLSonali M. Smith, MD

9:10 a.m. Relapsed and Refractory DLBCL – Role of HDT-ASCR in the ERA of CAR-T Cell TherapyCraig H. Moskowitz, MD

9:35 a.m. Burkitt Lymphoma – R-EPOCH for All?Mark J. Roschewski, MD

10:00 a.m. Concurrent Systemic and CNS Aggressive NHL: How to Manage?Philip J. Bierman, MD

10:25 a.m. Refreshment Break

Aggressive T-Cell LymphomasMODERATORS: Matthew A. Lunning, DO/Tara M. Graff, DO, MS

10:40 a.m. Update on T-Cell Lymphomas in WHO ClassificationDennis D. Weisenburger, MD

11:05 a.m. Therapy for CD 30+ PTCL Subtypes Steven M. Horwitz, MD

11:30 a.m. Treatment for Tumor Stage/Transformed Mycosis FungoidesYoun H. Kim, MD

11:55 a.m. NK/T Cell Lymphoma: Updated Therapies and Improved OutcomesWon Seog Kim, MD, PhD

12:20 p.m. You Make the Call: Transplant in T-Cell Lymphoma SubtypesSonali M. Smith, MDKerry J. Savage, MD, MScJasmine M. Zain, MD

12:45 p.m. Adjourn

Lymphoma Jeopardy – Semi-FinalsMODERATOR: Matthew A. Lunning, DO

3:00 p.m. Pineapple Cup Lymphoma Jeopardy Semifinals #1 TEAM 1:Kieron M. Dunleavy, MDJeremy S. Abramson, MD Nathan H. Fowler, MDMatthew S. Davids, MD, MMSc

TEAM 2:Steven M. Horwitz, MDBrad S. Kahl, MDKerry J. Savage, MD, MSc Sonali M. Smith, MD

4:00 p.m. Pineapple Cup Lymphoma Jeopardy Semifinals #2TEAM 3:David G. Maloney, MD, PhDRichard I. Fisher, MDBruce D. Cheson, MDLeo I. Gordon, MD, FACP

TEAM 4:Wyndham H. Wilson, MD, PhDThomas E. Witzig, MDJonathan W. Friedberg, MD,

MMScRanjana H. Advani, MD

5:00 p.m. Adjourn

Thursday, July 19, 2018 7:00 a.m. Continental Breakfast

Hodgkin LymphomaMODERATORS: Theresa Franco, MSN, RN/Thomas E. Witzig, MD

7:20 a.m. Hodgkin Upfront Therapy in Germany vs the US Ranjana H. Advani, MD Andreas Engert, MD

7:55 a.m. Use of Total Metabolic Tumor Volume (TMTV) in PET Scans Neil J. Hansen, MD

8:20 a.m. Radiation Therapy for Localized LP Hodgkin Richard T. Hoppe, MD

8:45 a.m. Hodgkin Lymphoma: First Relapse Options Barbara Pro, MD

9:10 a.m. Transplant in Hodgkin Lymphoma: Still After First Relapse?Craig H. Moskowitz, MD

9:35 a.m. Beyond Check Point Inhibitors for Hodgkin LymphomaStephen M. Ansell, MD, PhD

10:00 a.m. Refreshment Break

Multiple Myeloma/Plasma Cell DyscrasiaMODERATORS: Eric J. Avery, MD/Julie M. Vose, MD, MBA

10:20 a.m. New Induction Therapies for Multiple MyelomaSarah Holstein, MD, PhD

10:45 a.m. Relapsed and Refractory Multiple Myeloma – Sequencing Therapies Sagar Lonial, MD

11:10 a.m. Castleman’s Disease Angela Dispenzieri, MD

11:35 a.m. Amyloid ManagementAngela Dispenzieri, MD

12:00 p.m. Pineapple Cup Lymphoma FinalsWinners from Preliminaries

12:30 p.m. Adjourn

Ask the Experts

3:00 p.m. Clinical Cases Discussing Treatment and Sequencing of Agents in Indolent Non-HodgkinLymphoma and Chronic Lymphocytic Leukemia MODERATOR: Thomas E. Witzig, MDNathan H. Fowler, MDLeo I. Gordon, MD, FACPRichard I. Fisher, MD

4:00 p.m. Clinical Cases Discussing Upfront, Relapsed, and Transplant Options for Patients with ALL and Lymphoblastic LymphomaModerator: Philip J. Bierman, MDVijaya Raj Bhatt, MBBSWendy Stock, MD Susan M. O’Brien, MD

5:00 p.m. Adjourn

7:00 p.m. Conference Dinner

Friday, July 20, 2018 7:00 a.m. Continental Breakfast

Common Indolent LymphomasMODERATORS: Christopher J. Kratochvil, MD/Julie M. Vose, MD, MBA

7:30 a.m. The Microenvironment in Indolent Lymphomas: Targeting with Combination Therapies John G. Gribben, MD, DSc, FRCP, FRCPath, FMed Sci

7:55 a.m. CLL: How To Sequence Therapy Options Susan M. O’Brien, MD

8:20 a.m. Mantle Cell Lymphoma – Controlled or Cured? Andre H. Goy, MD, MPH

8:45 a.m. Follicular Lymphoma: Novel Combination Therapies Jonathan W. Friedberg, MD, MMSc

9:10 a.m. Multiple Facets of Marginal Zone Lymphoma Emanuele Zucca, MD

9:35 a.m. Refreshment Break

Conference Agenda (continued)

Uncommon Indolent LymphomaMODERATORS: Matthew A. Lunning, DO

9:55 a.m. Waldenstrom’s Macroglobulinemia: Optimal Treatment Sequencing Irene M. Ghobrial, MD

10:20 a.m. Best Management of LGL After Methotrexate or Cytoxan R. Gregory Bociek, MD, MSc, FRCP(C)

10:45 a.m. Best Management of LyP After Methotrexate FailsSteven M. Horwitz, MD

11:10 a.m. Management of Lymphomatoid GranulomatosisWyndham H. Wilson, MD, PhD

11:35 a.m. Clinical Trials for Patients with Lymphoma: How to Enroll More PatientsJohn P. Leonard, MD

12:00 p.m. Take Home Messages from PPLC 2018Matthew A. Lunning, DO

12:30 p.m. Adjourn

Call for AbstractsThe Conference Directors welcome submission of abstracts for the 2018 Pan Pacific Lymphoma Conference. Abstracts must be submitted online at unmc.edu/panpacificlymphoma by April 6, 2018.

Authors will receive final notification of abstract acceptance via email by April 27, 2018. All accepted abstracts will be presented as posters at the conference. Time will be dedicated during the continental breakfasts and refreshment breaks for poster viewing.

Travel StipendsThe Pan Pacific Lymphoma Conference will provide a limited number of stipends ($1000 value) to fellows-in-training, junior faculty* members, or nurses who are accepted as poster presenters.

To be considered for a travel stipend, a letter from the department chair, chief of staff, or director verifying status, must be submitted online along with the abstract by April 6, 2018.

The stipends will be awarded in the following manner:

• the conference registration will be waived; and

• two (2) nights’ lodging plus tax at the Hyatt Regency Maui Resort & Spa will be paid directly by the Pan Pacific Lymphoma Conference

Stipend recipients must stay at the Hyatt Regency Maui Resort & Spa in order to accept this stipend. No direct funds will be disbursed.

*Junior faculty is defined as a faculty member of three years or less.

Conference FacultyJeremy S. Abramson, MDDirector, Center for Lymphoma, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School, Boston, MA

Ranjana H. Advani, MDSaul A. Rosenberg Professor of Lymphoma, Department of Medicine/Oncology, Stanford Cancer Institute, Stanford University Medical Center, Stanford, CA

Stephen M. Ansell, MD, PhDChair, Mayo Clinic Lymphoma Group; Professor of Medicine, Mayo Clinic, Rochester, MN

James O. Armitage, MD

Joe Shapiro Professor of Medicine, Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

Eric J. Avery, MDNebraska Hematology Oncology, Lincoln, NE

Nancy L. Bartlett, MDProfessor of Medicine, Koman Chair in Medical Oncology, Washington University School of Medicine, St. Louis, MO

Vijaya Raj Bhatt, MBBSAssistant Professor, Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

Philip J. Bierman, MDProfessor, Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

Susan Blumel, RN, BSNClinical Study Nurse Coordinator, Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

R. Gregory Bociek, MD, MSc, FRCP(C)Associate Professor, Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

Peggy Burhenn, MS, RN-BC, AOCNSProfessional Practice Leader, Geriatric Oncology, City of Hope National Medical Center, Duarte, CA

Bruce D. Cheson, MDDeputy Chief, Hematology-Oncology; Professor of Medicine; Head of Hematology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC

Matthew S. Davids, MD, MMScAssociate Director, CLL Center, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, Boston, MA

Daniel J. DeBehnke, MD, MBAChief Executive Officer, Nebraska Medicine; Professor, Department of Emergency Medicine; Senior Associate Dean – Health System, University of Nebraska Medical Center, Omaha, NE

Angela Dispenzieri, MDProfessor of Medicine; Professor of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Kieron M. Dunleavy, MDProfessor of Medicine, George Washington University; Lymphoma Program Director, George Washington Cancer Center, Washington, DC

Andreas Engert, MDProfessor of Internal Medicine, Hematology and Oncology, University Hospital of Cologne, Cologne, Germany

Richard I. Fisher, MDPresident and CEO, The Robert C. Young MD Chair in Cancer Research, Fox Chase Cancer Center – Temple Health; Senior Associate Dean, Temple University School of Medicine, Philadelphia, PA

Nathan H. Fowler, MDAssociate Professor; Director, Clinical and Translational Research, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Theresa Franco, MSN, RNVice President, Cancer Center Clinical Operations & Radiology, Fred & Pamela Buffett Cancer Center, Nebraska Medicine, Omaha, NE

Jonathan W. Friedberg, MD, MMScDirector, James P. Wilmot Cancer Center; Samuel Durand Professor of Medicine, University of Rochester Medical Center, Rochester, NY

Irene M. Ghobrial, MDAssociate Professor of Medicine, Harvard Medical School; Director, Michele & Steven Kirsch Laboratory; Director, Clinical Investigator Research Program; Senior Physician, Dana-Farber Cancer Institute, Boston, MA

Sergio A. Giralt, MDMelvin Berlin Family Chair in Myeloma Research; Professor of Medicine, Weill Cornell Medical College; Attending, Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY

Jeffrey P. Gold, MDChancellor, University of Nebraska Medical Center and University of Nebraska Omaha; Chairman of the Board, Nebraska Medicine, Omaha, NE

Leo I. Gordon, MD, FACPAbby and John Friend Professor of Oncology Research; Professor of Medicine; Director, Lymphoma Program; Co-Director, Hematologic Malignancies Program, Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center; Medical Director, The Mathews Center for Cellular Therapy, Northwestern Memorial Hospital, Northwestern University, Chicago, IL

Andre H. Goy, MD, MPHChairman and Executive Director, John Theurer Cancer Center, Hackensack University Medical Center; Chief Science Officer; Director of Research and Innovation, Regional Cancer Care Associates, Hackensack, NJ

Tara M. Graff, DO, MSMedical Oncology and Hematology Associates of Iowa, Des Moines, IA

Timothy C. Greiner, MDAmelia F. and Austin L. Vickery, Jr. Professor; Director of Hematopathology Fellowship, Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE

John G. Gribben, MD, DSc, FRCP, FRCPath, FMed SciHamilton Fairley Professor of Medical Oncology, Barts Cancer Institute, Queen Mary School of Medicine, University of London, London, England, UK

Neil J. Hansen, MDAssistant Professor, Division of Body Imaging and Nuclear Medicine, Department of Radiology, University of Nebraska Medical Center, Omaha, NE

Sarah A. Holstein, MD, PhDAssociate Professor, Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

Richard T. Hoppe, MDHenry S. Kaplan-Henry Lebeson Professor of Cancer Biology; Professor, Radiation Oncology-Radiation Therapy; Member, Cancer Institute, Stanford University School of Medicine, Stanford, CA

Steven M. Horwitz, MDAssociate Attending, Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

Conference Director

Brad S. Kahl, MDProfessor of Medicine; Director, Lymphoma Program, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO

Won Seog Kim, MD, PhDProfessor, Division of Hematology-Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea

Youn H. Kim, MDJoanne and Peter Haas, Jr. Professor; Director, Multidisciplinary Cutaneous Lymphoma Program, Stanford University School of Medicine and Cancer Institute, Stanford, CA

Christopher J. Kratochvil, MDAssociate Vice Chancellor for Clinical Research, University of Nebraska Medical Center; Vice President for Research, Nebraska Medicine; Chief Medical Officer, UNeHealth, Omaha, NE

David M. Kurtz, MD, PhDPostdoctoral Medical Fellow - Oncology, Stanford University, Stanford, CA

John P. Leonard, MDRichard T. Silver Distinguished Professor of Hematology and Medical Oncology; Associate Dean for Clinical Research, Weill Cornell Medical College; Vice Chairman of Medicine for Clinical Research; Associate Director, Meyer Cancer Center; Attending Physician, New York Presbyterian Hospital, New York, NY

Susanne E. Liewer, PharmD, BCOP, FHOPAPharmacy Coordinator - Blood and Marrow Transplant, Nebraska Medicine; Clinical Associate Professor, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE

Sagar Lonial, MDChair and Professor, Department of Hematology and Medical Oncology; Chief Medical Officer, Winship Cancer Institute, Emory University, Atlanta, GA

Matthew A. Lunning, DO

Assistant Professor, Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

David G. Maloney, MD, PhDMember, Clinical Research Division, Fred Hutchinson Cancer Research Center; Professor of Medicine, Division of Oncology, University of Washington, Seattle, WA

Craig H. Moskowitz, MDSteven A. Greenberg Chair in Lymphoma Research; Attending Physician, Lymphoma and Adult BMT Services; Member, Memorial Sloan-Kettering Cancer Center; Professor of Medicine, Weill Cornell Medical College, Cornell University, New York, NY

Susan M. O’Brien, MDProfessor of Medicine; Associate Director for Clinical Science, Chao Family Comprehensive Cancer Center; Medical Director, Sue and Ralph Stern Center for Cancer Clinical Trials and Research, University of California/Irvine, Orange, CA

Katrina Pose Sabati, MPA, PA-CPhysician Assistant, University of California Los Angeles (UCLA) Hematology and Bone Marrow Transplant, Los Angeles, CA

Barbara Pro, MDProfessor of Medicine, Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL

Jean Ridgeway, DNP, APN, NP-C, AOCNDirector, Advance Practice Providers, Hematology/Oncology; Advance Practice Nurse, Section of Hematology/Oncology, Department of Medicine, The University of Chicago Medicine, Chicago, IL

Mark J. Roschewski, MDStaff Clinician, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD

Kerry J. Savage, MD, MScAssociate Professor of Medicine, University of British Columbia; Medical Oncologist, BC Cancer Agency, Vancouver, British Columbia, Canada

Stephen J. Schuster, MDDirector, Lymphoma Program; Robert and Margarita Louis-Dreyfuss Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Laurie H. Sehn, MD, MPHChair, Lymphoma Tumour Group, BC Cancer Agency, Centre for Lymphoid Cancer; Clinical Professor, University of British Columbia, Vancouver, British Columbia, Canada

Sonali M. Smith, MDProfessor of Medicine, Section of Hematology/Oncology; Director, Lymphoma Program, The University of Chicago, Chicago, IL

Wendy Stock, MDAnjuli Seth Nayak Professor of Medicine; Director, Leukemia Program; Section of Hematology/Oncology, The University of Chicago, Chicago, IL

Julie M. Vose, MD, MBA

Neumann M. and Mildred E. Harris Professor and Chief, Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE

Dennis D. Weisenburger, MDProfessor and Chair, Department of Pathology, City of Hope National Medical Center, Duarte, CA

Wyndham H. Wilson, MD, PhDDeputy Chief, Lymphoid Malignancies Branch; Chief, Lymphoid Malignancy Therapeutics Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD

Thomas E. Witzig, MDProfessor of Medicine, Mayo Medical School; Associate Director of Translational Research; Deputy Director for Clinical Research, Mayo Clinic Cancer Center, Rochester, MN

Jasmine M. Zain, MDDirector T Cell Lymphoma Program, Toni Stephenson Lymphoma Center, City of Hope National Medical Center, Duarte, CA

Andrew D. Zelenetz, MD, PhDVice Chair, Medical Informatics, Department of Medicine; Attending Physician, Lymphoma Service, Memorial Sloan-Kettering Cancer Center; Professor of Medicine, Weill Cornell Medical College, New York, NY

Laura Zitella, MS, RN, ACNP-BC, AOCNLead Advanced Practice Provider/Nurse Practitioner, Inpatient Hematology/Oncology, Stanford Health Care, Stanford, CA

Emanuele Zucca, MDHead, Lymphoma Unit, Oncology Institute of Southern Switzerland; Ospedale San Giovanni, Titular Professor of Medicine, University of Bern, Bellinzona, Switzerland

Hotel and Travel InformationHotel AccommodationsA block of resort view rooms has been reserved at the Hyatt Regency Maui Resort & Spa from July 13-23, 2018.

Room RatesResort/Mountain View — $347Partial Ocean View — $369Deluxe Ocean View — $389Premier Ocean Front — $399

The maximum occupancy per room is 4.

There is no charge for children 18 years and under sharing the same room as the parents and using existing bedding which consists of either one king or one queen with one double.

Other Charges• Extra Person — $75 per room per night• Rollaways — $25 per night based on availability • Food and Beverage — A 23% service charge and applicable

taxes shall be added to all food and beverage• Porterage — $12 per person (includes children of all ages) plus

Hawaii state tax. This rate is based on two bags per person. This charge is automatically posted to the individual’s folio

• Housekeeping Gratuities — $5.50 per room per day is recommended (up to individual’s discretion)

• Resort Fee — $10 per room per night plus Hawaii state tax. The Daily Resort Fee is automatically posted to the individual’s folio

Hyatt Regency Maui Resort & Spa200 Nohea Kai Drive, Lahaina, HI 96761

To Make Your ReservationGo to aws.passkey.com/event/49291209/owner/59421/home or call 888-421-1442 and identify yourself with the UNMC Pan Pacific Lymphoma Conference group. Reservations will be guaranteed upon receipt of two (2) nights’ deposit. This block rate is available on a first come, first serve basis until May 4, 2018. After this date, reservations will be accepted on a space and rate availability basis.

Go to unmc.edu/panpacificlymphoma for hotel cancellation policy and other information.

Air TravelTravel and Transport has been designated the official conference travel management company. To receive available conference discounts, call 877-541-1088 (hours of operation Monday through Friday, 8 am - 5 pm) or email lnk@tandt.com and identify yourself with the UNMC Pan Pacific Lymphoma Conference.

There is a standard $37 per domestic airline ticket fee (with a family cap of $90) and a $47 per international airline ticket fee (with a family cap of $125).

AirportThe two closest airports to the Hyatt Regency Maui Resort & Spa are Kahului Airport/OGG (approximately 27 miles) and Kapalua West Maui Airport/JHM (approximately 4 miles).

AttireCasual dress is encouraged for the entire conference. Layered clothing is recommended as the temperature in meeting rooms can fluctuate. A light jacket or sweater for outdoor evening activities is suggested.

REGISTRATION FORM — CID 26105

July 16-20, 2018

Hyatt Regency Maui Resort & Spa Maui, Hawaii

Participant Information

Name

Degree or Profession

Specialty

Institutional/Corporate Affiliation

Mailing Address (Line 1)

Mailing Address (Line 2)

City State

ZIP/Postal Code Country

Office Phone Home Phone

Fax Number Birthdate

*Email Address

†American Board of Internal Medicine (ABIM) ID Number

†Nursing License Number †State Issued

†National Association of Boards of Pharmacy (NABP) e-Profile ID

Please indicate if you require any special accommodations (such as dietary, mobility, hearing, etc).

First Name Last Name

(including country and area code) (including country and area code)

(including country and area code)

Required: Registration confirmation will be sent via email.

mm/dd

Suffix

Conference Registration FeesBy

May 15After

May 15

Physicians $675 $775 $

Nurses and All Other Healthcare Providers $475 $575 $

Pharmaceutical and Other Healthcare Industry Attendees $1000 $1250 $

Accompanying Guest(s) FeeNumber of guest(s) under 12 (No fee)

Number of guest(s) over 12 x $225 $

Registered family members or friends may accompany the conference attendee for breakfasts and breaks from Monday through Friday, at the Welcome Reception on Tuesday evening, and the Conference Dinner on Thursday evening. Name tags will be issued and required at these food functions.

Name(s) Age(s)

Full payment must accompany the conference registration.

Total Amount $

Payment Check or money order (in USD drawn on a US bank) made

payable to the UNMC Center for Continuing Education

Credit card

AmEx Discover MasterCard Visa

Name on card

Card Number

Exp Date CVC

Signature

1-5 13-18 6-12 19+

1-5 13-18 6-12 19+

1-5 13-18 6-12 19+

1-5 13-18 6-12 19+

1-5 13-18 6-12 19+

Pan Pacific Lymphoma Conference20182018

Return toUNMC Center for Continuing Education Phone: 402-559-5929◊

986800 Nebraska Medical Center Toll Free: 877-832-6924Omaha, NE 68198-6800 Fax: 402-559-5915

Registration Deadline: June 22, 2018

*Required†US only (Optional)

◊Available Monday through Friday from 8 a.m. - 4 p.m. CT

Required for claiming pharmacy credit

CENTER FOR CONTINUING EDUCATION 986800 Nebraska Medical Center Omaha, NE 68198-6800

CID 26105

NON PROFITUS POSTAGE

P A I DOMAHA, NE

PERMIT NO. 454

Learn from cutting edge presentations and exchange ideas with over 400 renowned clinicians, scientists, experts, and colleagues from across the US and around the globe who are involved in the treatment and management of lymphoma patients.

Pan Pacific Lymphoma ConferencePan Pacific Lymphoma Conference20182018 July 16-20

Maui, HawaiiJuly 16-20Maui, Hawaii

DATES TO REMEMBERApril 6, 2018 — Deadline for abstract submissionMay 4, 2018 — Deadline for hotel registrationMay 15, 2018 — Register by this date to receive the discounted registration rateJune 22, 2018 — Deadline for conference registration

unmc.edu/panpacificlymphoma